WHO naming stem · anywhere in the name · 30 listed names
erg
This page was written with AI.
ergot alkaloid derivatives
Where it sits in a name
WHO writes the stem as erg, without hyphens, which means it can sit anywhere in a name. So the letters erg sit anywhere in the name (erg).
All 30 names WHO lists under erg
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 5 of 30 names appear in these lists: 5 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 6 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- acetergamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amesergideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brazergolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bromergurideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cabergolineEU (central) brands: none found
- cianergolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- delergotrileNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dihydroergotamineUS brands: ATZUMI, BREKIYA (AUTOINJECTOR), MIGRANAL, TRUDHESA, D.H.E. 45 (discontinued in FDA listings)EU (central) brands: none found
- disulergineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dosergosideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ergometrineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ergotamineUS brands: ERGOMAR, ERGOSTAT (discontinued in FDA listings), MEDIHALER ERGOTAMINE (discontinued in FDA listings), WIGRETTES (discontinued in FDA listings)in combination: MIGERGOT with caffeine; CAFERGOT (discontinued in FDA listings) with caffeine; WIGRAINE (discontinued in FDA listings) with caffeineEU (central) brands: none found
- etisulergineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fludihydroergotamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lergotrileNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lysergideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mergocriptineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mesulergineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- metergolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- metergotamineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- methysergideEU (central) brands: none found
- nicergolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pergolideEU (central) brands: none found
- propisergideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- protergurideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- romergolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sergolexoleNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tergurideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tiomergineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- voxergolideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not ergot alkaloid derivatives
WHO lists this name under erg, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In this name, WHO’s definition of erg does not apply.
- ergocalciferol
Decode another name
Decoded
lysergide
Listed INNCarries the WHO stem erg
- erginside the nameWHO lists it hereWHO definition: ergot alkaloid derivatives
“lysergide” is an INN that WHO lists under erg in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of erg (Part II B) and the 30 names (Part IV, group (a)), and the 1 not in accordance with it (group (b)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.